These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38928525)

  • 1. Utility of Combining Transcranial Sonography and MIBG Myocardial Scintigraphy to Evaluate Substantia Nigra in Patients with Parkinson's Disease.
    Mizukami H; Shiraishi M; Hino S; Kaburagi M; Matsumoto H; Hagiwara Y; Yamano Y
    Brain Sci; 2024 May; 14(6):. PubMed ID: 38928525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial sonography of the substantia nigra and MIBG myocardial scintigraphy: complementary role in the diagnosis of Parkinson's disease.
    Kajimoto Y; Miwa H; Okawa-Izawa M; Hironishi M; Kondo T
    Parkinsonism Relat Disord; 2009 May; 15(4):270-2. PubMed ID: 18691928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
    Izawa MO; Miwa H; Kajimoto Y; Kondo T
    Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of transcranial sonographic findings and MIBG cardiac scintigraphy in the diagnosis of idiopathic Parkinson's disease.
    Behnke S; Hellwig D; Bürmann J; Runkel A; Farmakis G; Kirsch CM; Fassbender K; Becker G; Dillmann U; Spiegel J
    Parkinsonism Relat Disord; 2013 Nov; 19(11):995-9. PubMed ID: 23880025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: comparison with DAT PET scans.
    Liu P; Li X; Li FF; Ou-Yang QH; Zhang HX; Feng T
    Neurosci Lett; 2014 Oct; 582():99-103. PubMed ID: 25218716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of dopamine transporter imaging (DAT-SPECT) and
    Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
    J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial sonography in relation to SPECT and MIBG.
    Kajimoto Y; Miwa H; Kondo T
    Int Rev Neurobiol; 2010; 90():48-62. PubMed ID: 20692493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
    Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
    Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: a case series study].
    Yamada A; Murakami T; Kang Y; Iikuni Y; Morimatsu A; Shirata A; Ito H; Ugawa Y; Yamane K
    Rinsho Shinkeigaku; 2016 Jun; 56(6):400-6. PubMed ID: 27212677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease.
    Fan Y; Ma J; Yang D; Li X; Liang K; She Z; Qi X; Shi X; Gu Q; Zheng J; Li D
    Eur J Neurosci; 2024 May; 59(10):2702-2714. PubMed ID: 38469656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopamine activity and myocardial
    Oh YS; Kim JS; Yoo SW; Hwang EJ; Lyoo CH; Lee KS
    Parkinsonism Relat Disord; 2019 Jun; 63():156-161. PubMed ID: 30796009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High clinical diagnostic accuracy of combined salivary gland and myocardial metaiodobenzylguanidine scintigraphy in the diagnosis of Parkinson's disease.
    Li S; Yue L; Chen S; Wu Z; Zhang J; Hong R; Xie L; Peng K; Wang C; Lin A; Jin L; Guan Q
    Front Aging Neurosci; 2022; 14():1066331. PubMed ID: 36711204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.
    Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ
    Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
    J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the substantia nigra echogenicity and
    Mašková J; Školoudík D; Štofaniková P; Ibarburu V; Kemlink D; Zogala D; Trnka J; Krupička R; Šonka K; Růžička E; Dušek P
    Sleep Med; 2020 Jun; 70():116-123. PubMed ID: 32403038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Utility of the Combined Use of
    Matsusue E; Fujihara Y; Tanaka K; Aozasa Y; Shimoda M; Nakayasu H; Nakamura K; Ogawa T
    Yonago Acta Med; 2018 Jun; 61(2):117-127. PubMed ID: 29946218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.